Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Post by firesIayer96on Oct 08, 2012 12:15pm
482 Views
Post# 20461930

Huge potential for Core cervical cancer screening

Huge potential for Core cervical cancer screening

Obviously management's current focus is getting the Aura out the door. Kicking at the Aura's heels is the Core/lung, with news on this expected by the end of the year. There has not been much discussion on the Core as a screening tool for colon or cervical cancer. Huang's recent work at NUS suggests that there is huge potential for the Core to detect cervical cancer with excellent statisticals.

Zhiwei Huang, Cervical, Sensitivity 93%, Specificity 97%.

https://www.bioeng.nus.edu.sg/optbioimaging/Huang/publication/2009_High%20wavenumber%20Raman%20spectroscopy%20for%20in%20vivo%20detection%20of%20cervical%20dysplasia.pdf

Bullboard Posts